Writing long stretches of DNA is difficult and expensive. The Austrian biotech Ribbon Biolabs is combining automation with enzymes to make the process easier, with the prospect of improving synthetic biology applications.
Writing long stretches of DNA is difficult and expensive. The Austrian biotech Ribbon Biolabs is combining automation with enzymes to make the process easier, with the prospect of improving synthetic biology applications.